H&S INVESTMENTS I LP 4
4 · Sensei Biotherapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
H&S INVESTMENTS I LP
10% Owner
Transactions
- Conversion
Common Stock
2021-02-08+4,361,835→ 4,425,998 total - Conversion
Series AA Convertible Preferred Stock
2021-02-08−209,368,245→ 0 total→ Common Stock (4,361,835 underlying)
Footnotes (2)
- [F1]Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.
- [F2]The shares are held by H&S Investments I, L.P ("H&S Investments"), H&S Ventures, LLC ("H&S Ventures"), its general partner, and Michael Shulman, manager of H&S Ventures may be deemed to have voting and dispositive power with respect to the shares held. Henry Samueli and Susan Samueli are the non-managing members of H&S Ventures and each have the right to replace the managing member of H&S Ventures at any time. Henry Samueli and Susan Samueli may be deemed to beneficially own any shares directly owned by H&S Investments.